Annexon
ANNX · NASDAQ
$3.83−$0.18 (−4.49%)TodayMarket closed ·
Prev close $4.01
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 12.1% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.2438 | -$0.28 | −14.8% |
| Q1 FY26 | -$0.2949 | -$0.23 | +22.0% |
| Q4 FY25 | -$0.319 | -$0.28 | +12.2% |
| Q3 FY25 | -$0.3468 | -$0.37 | −6.7% |
| Q2 FY25 | -$0.373 | -$0.34 | +8.8% |
| Q1 FY25 | -$0.3023 | -$0.37 | −22.4% |
| Q4 FY24 | -$0.2746 | -$0.33 | −20.2% |
| Q3 FY24 | -$0.2639 | -$0.25 | +5.3% |
Earnings calls
- ANNX - Earnings call Q2 2026
- Goldman Sachs 47th Annual Global Healthcare Conference 2026
- Bank of America Global Healthcare Conference 2026
- Special Call - Annexon, Inc.
- 44th Annual J.P. Morgan Healthcare Conference
- Cantor Global Healthcare Conference 2025
- Wells Fargo 20th Annual Healthcare Conference 2025
- Jefferies Global Healthcare Conference 2025
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.